| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $83,061,244 ) (Continued on the next page) |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UG1CA286954 | NCI Cancer Screening Research Network: Coordinating and Communication Center | 000 | 3 | NIH | 1/15/2026 | $1,354,658 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UG1CA287013 | Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) | 000 | 3 | NIH | 1/13/2026 | $1,346,937 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U19AI174242 | Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs | 000 | 4 | NIH | 2/19/2026 | $1,583,952 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA214057 | Developing CVD prediction models for women with early stage breast cancer | 000 | 6 | NIH | 1/19/2026 | $648,055 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA295226 | Optimizing pre-analytical variables for reliable mass spectrometry-based quantification of immunomodulatory proteins in cerebrospinal fluid in pediatric neuro-oncology trials | 000 | 2 | NIH | 3/3/2026 | $405,509 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R37CA286450 | Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy | 000 | 3 | NIH | 2/17/2026 | $601,181 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R37CA240832 | Novel Approaches to CD33-Directed Radioimmunotherapy | 000 | 8 | NIH | 12/5/2025 | $557,099 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R37CA234488 | Role of tumor cell cluster-induced signaling in breast cancer metastasis | 000 | 8 | NIH | 12/17/2025 | $362,340 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R37CA252050 | Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer | 000 | 6 | NIH | 4/2/2026 | $467,377 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM161275 | Mechanisms of Dynamic Cytoskeleton and Membrane Interactions | 000 | 1 | NIH | 2/27/2026 | $613,838 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35HL171556 | Promoting T cell reconstitution after hematopoietic cell transplantation | 001 | 3 | NIH | 3/27/2026 | $35,867 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35HL171556 | Promoting T cell reconstitution after hematopoietic cell transplantation | 000 | 3 | NIH | 2/9/2026 | $1,135,768 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM162410 | Visualization of native chromatin-associated complexes to elucidate chromatin regulatory mechanisms | 000 | 1 | NIH | 2/9/2026 | $484,000 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM144128 | Data analysis tools for leveraging massive public data to improve hypothesis-driven research | 000 | 6 | NIH | 2/23/2026 | $431,963 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM140823 | Mechanisms of transcriptional regulation and transcription factor specificity | 003 | 6 | NIH | 3/17/2026 | $1,105,868 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM139429 | Molecular mechanisms and functions of global chromatin control | 002 | 7 | NIH | 2/24/2026 | $813,090 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R21AI190571 | Statistical Methods for Assessing Immune Correlates of Risk and Protection Using Flexible Two-Phase Sampling Designs that Enrich Longitudinal Samples | 000 | 1 | NIH | 2/9/2026 | $220,000 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R21AI190539 | Multiplex binding antibody assay for confirmatory HSV-1/2 serological diagnosis | 000 | 1 | NIH | 4/1/2026 | $270,591 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R13OD024033 | Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference | 000 | 10 | NIH | 4/2/2026 | $57,000 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R13AI189265 | Flow Cytometry Workshops in Africa | 000 | 2 | NIH | 1/14/2026 | $69,132 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01NS109476 | Signaling Pathways that Modulate Neuronal Activity | 000 | 6 | NIH | 3/31/2026 | $512,963 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01NS109425 | Topographic mapping by cranial motor neurons - Renewal - Resubmission - 1 | 000 | 7 | NIH | 3/20/2026 | $443,010 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01HL168110 | Dormancy-dependent determination of hematopoietic stem cell fate from hemogenic endothelium | 000 | 4 | NIH | 3/19/2026 | $440,000 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01HL173520 | DLK1 regulates HSC quiescence through phase separation mediated inhibition of receptor signaling | 000 | 2 | NIH | 3/19/2026 | $646,305 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01HL173365 | CD90-targeted nanoparticles for in vivo hematopoietic stem cell gene therapy | 000 | 2 | NIH | 3/24/2026 | $756,008 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01HL161037 | Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | 001 | 6 | NIH | 3/13/2026 | $22,206 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01HL161037 | Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | 000 | 6 | NIH | 2/12/2026 | $703,183 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA295090 | MAPK-driven kinetochore stress in cancer | 000 | 2 | NIH | 4/1/2026 | $646,440 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA287573 | Interrogating roles for REST in small cell lung cancer therapy response and resistance | 000 | 3 | NIH | 12/8/2025 | $523,869 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA287476 | Interrogating a novel axis of tumor suppression in small cell lung cancer | 000 | 2 | NIH | 12/5/2025 | $494,025 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA285227 | Rational Vaccine Design to prevent HIV-Associated Lymphoma | 000 | 3 | NIH | 1/30/2026 | $560,212 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA298383 | Providing nicotine replacement therapy to enhance the efficacy of a smoking cessation smartphone app for Hispanic adults | 000 | 2 | NIH | 2/9/2026 | $647,926 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA297681 | Statistical Methods for Precision Prevention | 000 | 2 | NIH | 12/5/2025 | $455,052 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA277133 | Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies | 000 | 4 | NIH | 12/10/2025 | $361,548 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA276308 | Transcriptional-translational conflict in bladder epithelial homeostasis and cancer | 000 | 4 | NIH | 12/10/2025 | $512,155 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA262556 | Expanding the cancer paralog genetic interaction map to enable precision oncology | 000 | 3 | NIH | 2/26/2026 | $530,439 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA256969 | Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy | 000 | 6 | NIH | 3/23/2026 | $544,053 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI183406 | Deep Learning-based Protein Design of HIV-1 Env GP120 Core Immunogens for CD4 Binding Site Germline Targeting | 000 | 3 | NIH | 2/24/2026 | $841,429 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA114536 | Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy | 001 | 21 | NIH | 3/3/2026 | $0 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA114536 | Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy | 000 | 21 | NIH | 12/16/2025 | $392,157 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI147846 | Vaccine design to augment protective efficacy of antibodies against the EBV gH/gL glycoprotein complex | 001 | 7 | NIH | 3/30/2026 | $857,804 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI136946 | Mechanisms and consequence of helical shape generation in Helicobacter pylori | 000 | 9 | NIH | 1/30/2026 | $578,926 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI179712 | Metabolite- and cytokine-mediated signals interact to control human CD8 T cell responses in tissues | 000 | 2 | NIH | 1/10/2026 | $849,176 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI178284 | Role of local antibodies in control of chronic genital herpes | 000 | 3 | NIH | 1/3/2026 | $865,722 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI177095 | Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization | 000 | 3 | NIH | 1/30/2026 | $876,168 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI177078 | Statistical Methods for Advancing HIV Prevention | 000 | 4 | NIH | 1/30/2026 | $419,125 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI176563 | Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization | 000 | 4 | NIH | 1/17/2026 | $804,206 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI175535 | Defining Protective CMV Immunity after Transplantation | 000 | 4 | NIH | 2/24/2026 | $774,089 |
| | 2026 | 2026 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI173199 | Breastmilk antibodies regulate neonatal immunity to the microbiota | 000 | 4 | NIH | 1/24/2026 | $648,715 |
|
